Literature DB >> 5454321

Plasma digoxin concentrations in patients with atrial fibrillation.

D A Chamberlain, R J White, M R Howard, T W Smith.   

Abstract

Plasma digoxin concentrations were measured by radioimmunoassay in 116 patients with atrial fibrillation on long-term oral treatment with the drug, and in 23 patients with digoxin toxicity. The mean concentrations were 1.4 ng./ml. and 3.1 ng./ml., respectively. Though an overlap occurred between the therapeutic and toxic ranges, toxicity is unlikely to occur below a level of 2 ng./ml. Plasma concentration showed a poor correlation with resting heart rate during atrial fibrillation. In patients with good renal function, however, a significant correlation was found between oral dose and plasma concentration. No evidence was obtained for increased sensitivity to therapeutic concentrations of the drug in elderly subjects, but the doses required to achieve these concentrations tended to be less than in younger patients.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5454321      PMCID: PMC1701452          DOI: 10.1136/bmj.3.5720.429

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

2.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

3.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

4.  Digoxin metabolism in the elderly.

Authors:  G A Ewy; G G Kapadia; L Yao; M Lullin; F I Marcus
Journal:  Circulation       Date:  1969-04       Impact factor: 29.690

5.  Drug standards in military procurement.

Authors:  M Feinberg
Journal:  J Am Pharm Assoc       Date:  1969-03       Impact factor: 2.217

6.  Atrial fibrillation and digitalis toxicity.

Authors:  H D Friedberg
Journal:  Am Heart J       Date:  1969-03       Impact factor: 4.749

7.  Inhibition of binding of tritiated digoxin to myocardium by sodium depletion in dogs.

Authors:  C E Harrison; K G Wakim
Journal:  Circ Res       Date:  1969-02       Impact factor: 17.367

8.  The distribution and concentration of tritiated digoxin in human tissues.

Authors:  J E Doherty; W H Perkins; W J Flanigan
Journal:  Ann Intern Med       Date:  1967-01       Impact factor: 25.391

9.  Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Authors:  F I Marcus; L Burkhalter; C Cuccia; J Pavlovich; G G Kapadia
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

10.  Everest MS: Measurement of digoxin in plasma and its use in diagnosis of digoxin intoxication.

Authors:  D G Grahame-Smith
Journal:  Br Med J       Date:  1969-02-01
View more
  60 in total

1.  Editorial: Problems with digoxin.

Authors: 
Journal:  Br Med J       Date:  1975-01-11

2.  Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.

Authors:  B F Johnson; C Bye
Journal:  Br Heart J       Date:  1975-02

3.  Plasma and tissue digoxin concentrations in patients undergoing cardiopulmonary bypass.

Authors:  S G Carruthers; J Cleland; J G Kelly; S M Lyons; D G McDevitt
Journal:  Br Heart J       Date:  1975-03

4.  Serum digoxin concentrations.

Authors:  S M Dobbs; E M Rodgers; G E Mawer; W I Kenyon
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

5.  Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.

Authors:  H E Bøtker; P Toft; N A Klitgaard; E E Simonsen
Journal:  Br Heart J       Date:  1991-06

Review 6.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

7.  Biological availability of digoxin from Lanoxin produced in the United Kingdom.

Authors:  B F Johnson; A S Fowle; S Lader; J Fox; A D Munro-Faure
Journal:  Br Med J       Date:  1973-11-10

Review 8.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

9.  Plasma and urinary digoxin in thyroid dysfunction.

Authors:  G M Shenfield; J Thompson; D B Horn
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

10.  Long-term digoxin treatment in general practice.

Authors:  P Curtis
Journal:  Br Med J       Date:  1975-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.